|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Criscitiello C, Fumagalli D, Saini KS and
Loi S: Tamoxifen in early-stage estrogen receptor-positive breast
cancer: Overview of clinical use and molecular biomarkers for
patient selection. Onco Targets Ther. 4:1–11. 2010.PubMed/NCBI
|
|
4
|
Amiri-Kordestani L, Blumenthal GM, Xu QC,
Zhang L, Tang SW, Ha L, Weinberg WC, Chi B, Candau-Chacon R, Hughes
P, et al: FDA approval: Ado-trastuzumab emtansine for the treatment
of patients with HER2-positive metastatic breast cancer. Clin
Cancer Res. 20:4436–4441. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esteva FJ, Yu D, Hung MC and Hortobagyi
GN: Molecular predictors of response to trastuzumab and lapatinib
in breast cancer. Nat Rev Clin Oncol. 7:98–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Liu Y, Zhang C, Chu J, Wu Y, Li Y,
Liu J, Li Q, Li S, Shi Q, et al: Tamoxifen-resistant breast cancer
cells are resistant to DNA-damaging chemotherapy because of
upregulated BARD1 and BRCA1. Nat Commun. 9:15952018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Neophytou C, Boutsikos P and Papageorgis
P: Molecular mechanisms and emerging therapeutic targets of
triple-negative breast cancer metastasis. Front Oncol. 8:312018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Richard JL and Eichhorn PJ: Deciphering
the roles of lncRNAs in breast development and disease. Oncotarget.
9:20179–20212. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Costa FF: Non-coding RNAs, epigenetics and
complexity. Gene. 410:9–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding X, Zhu L, Ji T, Zhang X, Wang F, Gan
S, Zhao M and Yang H: Long intergenic non-coding RNAs (LincRNAs)
identified by RNA-seq in breast cancer. PLoS One. 9:e1032702014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Ye C, Xiong H, Shen Y, Lu Y, Zhou
J and Wang L: Dysregulation of long non-coding RNA in breast
cancer: An overview of mechanism and clinical implication.
Oncotarget. 8:5508–5522. 2017.PubMed/NCBI
|
|
13
|
Wang M, Wang M, Wang Z, Yu X, Song Y, Wang
C and Xu Y, Wei F, Zhao Y and Xu Y: Long non-coding
RNA-CTD-2108O9.1 represses breast cancer metastasis by influencing
leukemia inhibitory factor receptor. Cancer Sci. 109:1764–1774.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng R, Lin S, Guan L, Yuan H, Liu K, Liu
C, Ye W, Liao Y, Jia J and Zhang R: Long non-coding RNA XIST
inhibited breast cancer cell growth, migration, and invasion via
miR-155/CDX1 axis. Biochem Biophys Res Commun. 498:1002–1008. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao W, Geng D, Li S, Chen Z and Sun M:
LncRNA HOTAIR influences cell growth, migration, invasion, and
apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer
Med. 7:842–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tuo YL, Li XM and Luo J: Long noncoding
RNA UCA1 modulates breast cancer cell growth and apoptosis through
decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci.
19:3403–3411. 2015.PubMed/NCBI
|
|
17
|
Mao C, Wang X, Liu Y, Wang M, Yan B, Jiang
Y, Shi Y, Shen Y, Liu X, Lai W, et al: A G3BP1-interacting lncRNA
promotes ferroptosis and apoptosis in cancer via nuclear
sequestration of p53. Cancer Res. 78:3484–3496. 2018.PubMed/NCBI
|
|
18
|
Wang H, Li W, Guo R, Sun J, Cui J, Wang G,
Hoffman AR and Hu JF: An intragenic long noncoding RNA interacts
epigenetically with the RUNX1 promoter and enhancer chromatin DNA
in hematopoietic malignancies. Int J Cancer. 135:2783–2794. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin SX, Jiang H, Xiang GZ, Zhang WR, Weng
YH, Qiu FD, Wu J and Wang HG: Up-regulation of long non-coding RNA
SNHG1 contributes to proliferation and metastasis in laryngeal
squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 22:1333–1341.
2018.PubMed/NCBI
|
|
20
|
Wang Q, Li Q, Zhou P, Deng D, Xue L, Shao
N, Peng Y and Zhi F: Upregulation of the long non-coding RNA SNHG1
predicts poor prognosis, promotes cell proliferation and invasion,
and reduces apoptosis in glioma. Biomed Pharmacother. 91:906–911.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tan H, Zhao L, Song R, Liu Y and Wang L:
The long noncoding RNA SNHG1 promotes nucleus pulposus cell
proliferation through regulating miR-326 and CCND1. Am J Physiol
Cell Physiol. 315:C21–C27. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian T, Qiu R and Qiu X: SNHG1 promotes
cell proliferation by acting as a sponge of miR-145 in colorectal
cancer. Oncotarget. 9:2128–2139. 2017.PubMed/NCBI
|
|
23
|
Zheng S, Li M, Miao K and Xu H: SNHG1
contributes to proliferation and invasion by regulating miR-382 in
breast cancer. Cancer Manag Res. 11:5589–5598. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Visvader JE, Venter D, Hahm K, Santamaria
M, Sum EY, O'Reilly L, White D, Williams R, Armes J and Lindeman
GJ: The LIM domain gene LMO4 inhibits differentiation of mammary
epithelial cells in vitro and is overexpressed in breast cancer.
Proc Natl Acad Sci USA. 98:14452–14457. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wittlin S, Sum EY, Jonas NK, Lindeman GJ
and Visvader JE: Two promoters within the human LMO4 gene
contribute to its overexpression in breast cancer cells. Genomics.
82:280–287. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taniwaki M, Daigo Y, Ishikawa N, Takano A,
Tsunoda T, Yasui W, Inai K, Kohno N and Nakamura Y: Gene expression
profiles of small-cell lung cancers: Molecular signatures of lung
cancer. Int J Oncol. 29:567–575. 2006.PubMed/NCBI
|
|
27
|
Zhou X, Sang M, Liu W, Gao W, Xing E, Lü
W, Xu Y, Fan X, Jing S and Shan B: LMO4 inhibits p53-mediated
proliferative inhibition of breast cancer cells through interacting
p53. Life Sci. 91:358–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clarke C, Madden SF, Doolan P, Aherne ST,
Joyce H, O'Driscoll L, Gallagher WM, Hennessy BT, Moriarty M, Crown
J, et al: Correlating transcriptional networks to breast cancer
survival: A large-scale coexpression analysis. Carcinogenesis.
34:2300–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu X, Jin H, Liu Y, Liu L, Wu Q, Guo Y, Yu
L, Liu Z, Zhang T, Zhang X, et al: The expression patterns and
correlations of claudin-6, methy-CpG binding protein 2, DNA
methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and
acetyl-histone H4 and their clinicopathological significance in
breast invasive ductal carcinomas. Diagn Pathol. 7:332012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koleva-Kolarova RG, Greuter MJ, Feenstra
TL, Vermeulen KM, de Vries EF, Parkin D, Buskens E and de Bock GH:
Molecular imaging with positron emission tomography and computed
tomography (PET/CT) for selecting first-line targeted treatment in
metastatic breast cancer: A cost-effectiveness study. Oncotarget.
9:19836–19846. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lan X and Liu X: LncRNA SNHG1 functions as
a ceRNA to antagonize the effect of miR-145a-5p on the
down-regulation of NUAK1 in nasopharyngeal carcinoma cell. J Cell
Mol Med. 23:2351–2361. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sum EY, Segara D, Duscio B, Bath ML, Field
AS, Sutherland RL, Lindeman GJ and Visvader JE: Overexpression of
LMO4 induces mammary hyperplasia, promotes cell invasion, and is a
predictor of poor outcome in breast cancer. Proc Natl Acad Sci USA.
102:7659–7664. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Montañez-Wiscovich ME, Shelton MD,
Seachrist DD, Lozada KL, Johnson E, Miedler JD, Abdul-Karim FW,
Visvader JE and Keri RA: Aberrant expression of LMO4 induces
centrosome amplification and mitotic spindle abnormalities in
breast cancer cells. J Pathol. 222:271–281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang L, Shen X, Xie B, Ma Z, Chen X and
Cao F: Transcriptional profiling of differentially expressed long
non-coding RNAs in breast cancer. Genom Data. 6:214–216. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen C, Li Z, Yang Y, Xiang T, Song W and
Liu S: Microarray expression profiling of dysregulated long
non-coding RNAs in triple-negative breast cancer. Cancer Biol Ther.
16:856–865. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Q, Gao H, Zhou S and Liao Y: LncRNA
PlncRNA-1 overexpression inhibits the growth of breast cancer by
upregulating TGF-β1 and downregulating PHGDH. Breast Cancer.
25:619–625. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pan Y, Pan Y, Cheng Y, Yang F, Yao Z and
Wang O: Knockdown of lncRNA MAPT-AS1 inhibites proliferation and
migration and sensitizes cancer cells to paclitaxel by regulating
MAPT expression in ER-negative breast cancers. Cell Biosci.
8:72018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Sharma S and Watabe K: Roles of
lncRNA in breast cancer. Front Biosci (Schol Ed). 7:94–108. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li J, Wang W, Xia P, Wan L, Zhang L, Yu L,
Wang L, Chen X, Xiao Y and Xu C: Identification of a five-lncRNA
signature for predicting the risk of tumor recurrence in patients
with breast cancer. Int J Cancer. 143:2150–2160. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang S, Wang J, Ghoshal T, Wilkins D, Mo
YY, Chen Y and Zhou Y: lncRNA gene signatures for prediction of
breast cancer intrinsic subtypes and prognosis. Genes (Basel).
9:2018. View Article : Google Scholar
|
|
43
|
Zhu QN, Wang G, Guo Y, Peng Y, Zhang R,
Deng JL, Li ZX and Zhu YS: LncRNA H19 is a major mediator of
doxorubicin chemoresistance in breast cancer cells through a
cullin4A-MDR1 pathway. Oncotarget. 8:91990–92003. 2017.PubMed/NCBI
|
|
44
|
Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding
F, Li D and Yang T: Long noncoding RNA SNHG1 predicts a poor
prognosis and promotes hepatocellular carcinoma tumorigenesis.
Biomed Pharmacother. 80:73–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu Q, Shan S, Li Y, Zhu D, Jin W and Ren
T: Long noncoding RNA SNHG1 promotes non-small cell lung cancer
progression by up-regulating MTDH via sponging miR-145-5p. FASEB J.
32:3957–3967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun X, Wang Z and Yuan W: Down-regulated
long non-coding RNA SNHG1 inhibits tumor genesis of colorectal
carcinoma. Cancer Biomark. 20:67–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun Y, Wei G, Luo H, Wu W, Skogerbø G, Luo
J and Chen R: The long noncoding RNA SNHG1 promotes tumor growth
through regulating transcription of both local and distal genes.
Oncogene. 36:6774–6783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang L, Song G, Tan W, Qi M, Zhang L, Chan
J, Yu J, Han J and Han B: MiR-573 inhibits prostate cancer
metastasis by regulating epithelial-mesenchymal transition.
Oncotarget. 6:35978–35990. 2015.PubMed/NCBI
|
|
49
|
Danza K, De Summa S, Pinto R, Pilato B,
Palumbo O, Merla G, Simone G and Tommasi S: MiR-578 and miR-573 as
potential players in BRCA-related breast cancer angiogenesis.
Oncotarget. 6:471–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bai R, Weng C, Dong H, Li S, Chen G and Xu
Z: MicroRNA-409-3p suppresses colorectal cancer invasion and
metastasis partly by targeting GAB1 expression. Int J Cancer.
137:2310–2322. 2015. View Article : Google Scholar : PubMed/NCBI
|
